Maresin 1 biosynthesis and proresolving anti-infective functions with human-localized aggressive periodontitis leukocytes

Infection and Immunity

Volumn 84, Issue 3, 2016, Pages 658-665

  Wang, Chin Wei ^a,b,c   Colas, Romain A ^a   Dalli, Jesmond ^a   Arnardottir, Hildur H ^a   Nguyen, Daniel ^c   Hasturk, Hatice ^c   Chiang, Nan ^a   Van Dyke, Thomas E ^b,c   Serhan, Charles N ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c FORSYTH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; DOCOSAHEXAENOIC ACID; MARESIN 1; PEPTIDES AND PROTEINS; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; 7,14-DIHYDROXYDOCOSA-4,8,10,12,16,19-HEXAENOIC ACID;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; ARTICLE; BACTERIAL CLEARANCE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE; LOCALIZED AGGRESSIVE PERIODONTITIS; MACROPHAGE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTE; PHAGOCYTOSIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; BIOSYNTHESIS; CASE CONTROL STUDY; CELL CULTURE; FEMALE; GENETICS; IMMUNOLOGY; MALE; MICROBIOLOGY; PHYSIOLOGY;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; ARACHIDONATE 12-LIPOXYGENASE; CASE-CONTROL STUDIES; CELLS, CULTURED; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; LEUKOCYTES; MACROPHAGES; MALE; PHAGOCYTOSIS; PORPHYROMONAS GINGIVALIS;

EID: 84962138854     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01131-15     Document Type: Article

References (35)

1. Serhan CN. 2014. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510:92-101. http://dx.doi.org/10.1038/nature13479.
2. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. 2001. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2:612-619. http://dx.doi.org/10.1038/89759.
3. Serhan CN, Savill J. 2005. Resolution of inflammation: the beginning programs the end. Nat Immunol 6:1191-1197. http://dx.doi.org/10.1038/ni1276.
4. Serhan CN, Chiang N, Van Dyke TE. 2008. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349-361. http://dx.doi.org/10.1038/nri2294.
5. Nathan C, Ding A. 2010. Nonresolving inflammation. Cell 140:871-882. http://dx.doi.org/10.1016/j.cell.2010.02.029.
6. Van Dyke TE, Serhan CN. 2003. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 82:82-90. http://dx.doi.org/10.1177/154405910308200202.
7. Kantarci A, Oyaizu K, Van Dyke TE. 2003. Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J Periodontol 74:66-75. http://dx.doi.org/10.1902/jop.2003.74.1.66.
8. Lopez NJ, Mellado JC, Leighton GX. 1996. Occurrence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Prevotella intermedia in juvenile periodontitis. J Clin Periodontol 23:101-105. http://dx.doi.org/10.1111/j.1600-051X.1996.tb00541.x.
9. Slots J. 1976. The predominant cultivable organisms in juvenile periodontitis. Scand J Dent Res 84:1-10.
10. Mandell RL, Socransky SS. 1981. A selective medium for Actinobacillus actinomycetemcomitans and the incidence of the organism in juvenile periodontitis. J Periodontol 52:593-598. http://dx.doi.org/10.1902/jop.1981.52.10.593.
11. Fredman G, Oh SF, Ayilavarapu S, Hasturk H, Serhan CN, Van Dyke TE. 2011. Impaired phagocytosis in localized aggressive periodontitis: rescue by resolvin E1. PLoS One 6:e24422. http://dx.doi.org/10.1371/journal.pone.0024422.
12. Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF, Oh SF, Spite M. 2009. Maresins: novel macrophage mediators with potent anti-inflammatory and pro-resolving actions. J Exp Med 206:15-23. http://dx.doi.org/10.1084/jem.20081880.
13. Colas RA, Shinohara M, Dalli J, Chiang N, Serhan CN. 2014. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am J Physiol Cell Physiol 307:C39-C54. http://dx.doi.org/10.1152/ajpcell.00024.2014.
14. Serhan CN, Dalli J, Karamnov S, Choi A, Park CK, Xu ZZ, Ji RR, Zhu M, Petasis NA. 2012. Macrophage pro-resolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J 26:1755-1765. http://dx.doi.org/10.1096/fj.11-201442.
15. Deng B, Wang CW, Arnardottir HH, Li Y, Cheng CY, Dalli J, Serhan CN. 2014. Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages. PLoS One 9:e102362. http://dx.doi.org/10.1371/journal.pone.0102362.
16. Dalli J, Zhu M, Vlasenko NA, Deng B, Haeggstrom JZ, Petasis NA, Serhan CN. 2013. The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype. FASEB J 27:2573-2583. http://dx.doi.org/10.1096/fj.13-227728.
17. Armitage GC. 1999. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4:1-6. http://dx.doi.org/10.1902/annals.1999.4.1.1.
18. Gronert K, Kantarci A, Levy BD, Clish CB, Odparlik S, Hasturk H, Badwey JA, Colgan SP, Van Dyke TE, Serhan CN. 2004. A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage. J Immunol 172:1856-1861. http://dx.doi.org/10.4049/jimmunol.172.3.1856.
19. Majno G, Joris I. 2004. Bacterial killing: metabolic aspect of phagocytosis, p 419-422. In Majno G, Joris I (ed), Cells, tissues, and disease: principles of general pathology, 2nd ed. Oxford University Press, New York, NY.
20. Bazan NG. 1990. Supply of n-3 polyunsaturated fatty acids and their significance in the central nervous system, p 1-22. In Wurtman RJ, Wurtman JJ (ed), Nutrition and the brain, vol 8. Raven Press, New York, NY.
21. Calder PC. 2008. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids 79:101-108. http://dx.doi.org/10.1016/j.plefa.2008.09.016.
22. Cainciola LJ, Genco RJ, Patters MR, McKenna J, van Oss CJ. 1977. Defective polymorphonuclear leukocyte function in a human periodontal disease. Nature 265:445-447. http://dx.doi.org/10.1038/265445a0.
23. Van Dyke TE, Zinney W, Winkel K, Taufiq A, Offenbacher S, Arnold RR. 1986. Neutrophil function in localized juvenile periodontitis. Phagocytosis, superoxide production and specific granule release. J Periodontol 57:703-708.
24. Darveau RP. 2010. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol 8:481-490. http://dx.doi.org/10.1038/nrmicro2337.
25. Hillman JD, Socransky SS, Shivers M. 1985. The relationships between streptococcal species and periodontopathic bacteria in human dental plaque. Arch Oral Biol 30:791-795. http://dx.doi.org/10.1016/0003-9969(85)90133-5.
26. Han YW. 2015. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol 23:141-147. http://dx.doi.org/10.1016/j.mib.2014.11.013.
27. Oettinger-Barak O, Sela MN, Sprecher H, Machtei EE. 2014. Clinical and microbiological characterization of localized aggressive periodontitis: a cohort study. Aust Dent J 59:165-171. http://dx.doi.org/10.1111/adj.12165.
28. Yang NY, Zhang Q, Li JL, Yang SH, Shi Q. 2014. Progression of periodontal inflammation in adolescents is associated with increased number of Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythensis, and Fusobacterium nucleatum. Int J Paediatr Dent 24:226-233. http://dx.doi.org/10.1111/ipd.12065.
29. Bradshaw DJ, Marsh PD, Watson GK, Allison C. 1998. Role of Fusobacterium nucleatum and coaggregation in anaerobe survival in planktonic and biofilm oral microbial communities during aeration. Infect Immun 66:4729-4732.
30. Polak D, Wilensky A, Shapira L, Halabi A, Goldstein D, Weiss EI, Houri-Haddad Y. 2009. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response. J Clin Periodontol 36:406-410. http://dx.doi.org/10.1111/j.1600-051X.2009.01393.x.
31. Hajishengallis G. 2015. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol 15:30-44.
32. Chiang N, Fredman G, Bäckhed F, Oh SF, Vickery TW, Schmidt BA, Serhan CN. 2012. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484:524-528. http://dx.doi.org/10.1038/nature11042.
33. Spite M, Norling LV, Summers L, Yang R, Cooper D, Petasis NA, Flower RJ, Perretti M, Serhan CN. 2009. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461:1287-1291. http://dx.doi.org/10.1038/nature08541.
34. Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, Petasis NA, Levy BD, Serhan CN, Van Dyke TE. 2006. RvE1 protects from local inflammation and osteoclast mediated bone destruction in periodontitis. FASEB J 20:401-403.
35. Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, Van Dyke TE. 2007. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol 179:7021-7029. http://dx.doi.org/10.4049/jimmunol.179.10.7021.